Germany · Delayed Price · Currency is EUR Trellus Health Statistics
Total Valuation
Trellus Health has a market cap or net worth of EUR 1.77 million. The enterprise value is 450,173.
| Market Cap | 1.77M |
| Enterprise Value | 450,173 |
Important Dates
The next estimated earnings date is Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 161.51M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 14.86% |
| Owned by Institutions (%) | 68.72% |
| Float | 90.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.80 |
| PB Ratio | 0.24 |
| P/TBV Ratio | 1.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.08 |
| EV / Sales | 1.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.63
| Current Ratio | 3.63 |
| Quick Ratio | 3.63 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -56.65% and return on invested capital (ROIC) is -35.92%.
| Return on Equity (ROE) | -56.65% |
| Return on Assets (ROA) | -34.37% |
| Return on Invested Capital (ROIC) | -35.92% |
| Return on Capital Employed (ROCE) | -80.27% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 16,983 |
| Profits Per Employee | -325,841 |
| Employee Count | 18 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.63% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -65.63% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 57.47 |
| Average Volume (20 Days) | 1,119 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Trellus Health had revenue of EUR 305,689 and -5.87 million in losses. Loss per share was -0.04.
| Revenue | 305,689 |
| Gross Profit | 305,689 |
| Operating Income | -5.95M |
| Pretax Income | -5.87M |
| Net Income | -5.87M |
| EBITDA | -5.90M |
| EBIT | -5.95M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 1.34 million in cash and n/a in debt, with a net cash position of 1.34 million.
| Cash & Cash Equivalents | 1.34M |
| Total Debt | n/a |
| Net Cash | 1.34M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 7.41M |
| Book Value Per Share | 0.05 |
| Working Capital | 1.15M |
Cash Flow
| Operating Cash Flow | -5.24M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,946.51% |
| Pretax Margin | -1,918.66% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Trellus Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -331.04% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Trellus Health has an Altman Z-Score of -3.88 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.88 |
| Piotroski F-Score | 2 |